Robert E. Pitas

Active 1967–2008

Affiliations
Gladstone InstitutesUniversity of California, San FranciscoThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
43
Papers
11,074
Citations
43
h-index
43
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Robert E. Pitas1968: 1 citations1969: 1 citations1971: 1 citations1973: 1 citations1974: 1 citations1975: 1 citations1976: 1 citations1977: 1 citations1978: 10 citations1979: 13 citations1980: 25 citations1981: 27 citations1982: 41 citations1983: 47 citations1984: 29 citations1985: 27 citations1986: 53 citations1987: 41 citations1988: 47 citations1989: 42 citations1990: 54 citations1991: 64 citations1992: 60 citations1993: 72 citations1994: 98 citations1995: 99 citations1996: 89 citations1997: 129 citations1998: 170 citations1999: 151 citations2000: 260 citations2001: 181 citations2002: 152 citations2003: 119 citations2004: 167 citations2005: 132 citations2006: 134 citations2007: 64 citations2008: 89 citations2009: 85 citations2010: 146 citations2011: 89 citations2012: 82 citations2013: 60 citations2014: 82 citations2015: 54 citations2016: 61 citations2017: 38 citations2018: 44 citations2019: 123 citations2020: 129 citations2021: 114 citations2022: 81 citations2023: 74 citations2024: 75 citations2025: 46 citations1970: no citations, so this year is not shown1972: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Medicine59.7%
  • Biochemistry, Genetics and Molecular Biology23.3%
  • Neuroscience7%
  • Immunology and Microbiology5.2%
  • Nursing1.4%
  • Agricultural and Biological Sciences1.3%
  • Other2.1%

Topics

  • Alzheimer's disease research and treatments19.7%
  • Cholesterol and Lipid Metabolism12.4%
  • Lipoproteins and Cardiovascular Health9.3%
  • Peroxisome Proliferator-Activated Receptors7.6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.4%
  • Cancer, Lipids, and Metabolism6.2%
  • Other37.4%

Frequent coauthors

All papers

Loading papers…